Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

808
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
808
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

725
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
725
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.9K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

74
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
74

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulation and Outcomes After Traumatic Cerebral Venous Sinus Thrombosis: A Retrospective Cohort Study.

Journal of neurosurgical anesthesiology·2026
Same author

Social deprivation among people living with HIV in the French-swiss Cross-border area: the need for targeted interventions.

AIDS care·2026
Same author

Evaluating pertussis vaccine effectiveness in children under 5 years of age born in France between 2013 and 2019.

Vaccine·2026
Same author

Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: The BICARICU-2 Randomized Clinical Trial.

JAMA·2025
Same author

Combined effects of ciprofloxacin and microplastics on alpine spring water microbiota: evidence from glacier-fed microcosm experiments.

Frontiers in microbiology·2025

Related Experiment Video

Updated: Apr 21, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

11.6K

Optimizing antimicrobial therapy in critically ill patients.

Virginie Vitrat1, Serge Hautefeuille2, Cécile Janssen1

  • 1Antimicrobial Stewardship Program, Infectious Diseases Unit, Annecy, France.

Infection and Drug Resistance
|October 29, 2014
PubMed
Summary
This summary is machine-generated.

Improving antimicrobial use in intensive care units (ICUs) is crucial. Antimicrobial stewardship programs help optimize antibiotic prescriptions to combat rising resistance and improve patient outcomes in critical care settings.

Keywords:
ICUantimicrobial resistanceantimicrobial stewardshipantimicrobial therapiesearly diagnosispharmacodynamicspharmacokinetics

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

28.9K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 21, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

11.6K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

28.9K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

1.4K

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pharmacology

Background:

  • Infections in critically ill patients require timely bacterial identification and effective antimicrobial therapy.
  • Increasing antimicrobial resistance, particularly in Gram-negative pathogens, compromises treatment efficacy in intensive care units (ICUs).
  • Current diagnostic methods for bacterial identification are improving but remain costly and inaccessible in many healthcare settings.

Purpose of the Study:

  • To review multidisciplinary antimicrobial stewardship programs in ICUs.
  • To analyze the results, challenges, and pitfalls of these programs.
  • To emphasize the need for improved antimicrobial usage to prevent intractable infections.

Main Methods:

  • Literature review of antimicrobial stewardship interventions in ICUs.
  • Analysis of program outcomes related to antimicrobial prescription and resistance.
  • Examination of pharmacokinetic and pharmacodynamic principles in optimizing antimicrobial dosing.

Main Results:

  • Antimicrobial stewardship programs aim to enhance antimicrobial prescription practices.
  • Optimizing antimicrobial doses and schedules using pharmacokinetics and pharmacodynamics shows promise in improving outcomes and reducing resistance.
  • Combination therapies, while used to overcome resistance, can inadvertently promote further resistance.

Conclusions:

  • Effective interventions for improving antibiotic usage in ICUs are urgently needed.
  • Antimicrobial stewardship is essential for combating resistance and improving patient care in critical illness.
  • Failure to address antibiotic misuse risks future challenges with untreatable infections in critically ill patients.